X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-01 | AXLA | Koziel Margaret | Chief Medical Officer | S - Sale | $0.58 | -679 | 24,883 | -3% | -$394 | ||||||
2023-02-10 | AXLA | Fehlner Paul | SVP, GC | S - Sale | $0.66 | -5,221 | 58,081 | -8% | -$3,447 | ||||||
2022-10-19 | AXLA | Hinshaw William | Pres, CEO | S - Sale | $1.56 | -16,000 | 82,012 | -16% | -$25,027 | ||||||
2022-10-13 | AXLA | Flagship Ventures Fund IV General Partner LLC | 10% | P - Purchase | $1.64 | +10,383,760 | 29,251,545 | +55% | +$17,029,366 | ||||||
2022-10-13 | AXLA | Societe Des Produits Nestle S.A. | 10% | P - Purchase | $1.64 | +3,658,536 | 11,105,438 | +49% | +$5,999,999 | ||||||
2022-09-06 | AXLA | Koziel Margaret | Chief Medical Officer | S - Sale | $2.52 | -547 | 25,562 | -2% | -$1,378 | ||||||
2022-06-01 | AXLA | Koziel Margaret | Chief Medical Officer | S - Sale | $2.01 | -590 | 26,109 | -2% | -$1,186 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |